Bulimia Nervosa
138
28
33
71
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Research Maturity
71 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.2%
10 terminated out of 138 trials
87.7%
+1.1% vs benchmark
3%
4 trials in Phase 3/4
14%
10 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 71 completed trials
Clinical Trials (138)
Ketone Supplementation in Eating Disorders
Effects of Negative Affect in Individuals With Binge Eating Episodes
Eating Disorder Dynamic Intervention
Eating Disorders Genetics Initiative 2
The ITA Model of Integrated Treatment of Eating Disorders
The Dialogue Study: A Virtual-reality Based Treatment for Eating Disorders
MDMA Assisted Therapy for BN
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
Targeting Social Function in Anxiety and Eating Disorders
Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa
Relationships Between Exercise and Appetite in Women With Loss of Control Eating
Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa
Cognitive Evaluation of Patients With Eating Disorders
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
Epidemiological Study on the Prevalence of Mental Disorders in Slovakia
Changes in Inhibition and Valuation After Eating
Self-Control in Bulimia Nervosa
Neurofeedback During Eating for Bulimia Nervosa